Form 8-K - Current report:
SEC Accession No. 0000950170-25-017458
Filing Date
2025-02-11
Accepted
2025-02-11 07:30:08
Documents
11
Period of Report
2025-02-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K cytk-20250210.htm   iXBRL 8-K 43635
  Complete submission text file 0000950170-25-017458.txt   157691

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cytk-20250210.xsd EX-101.SCH 25033
13 EXTRACTED XBRL INSTANCE DOCUMENT cytk-20250210_htm.xml XML 4753
Mailing Address 350 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 350 OYSTER POINT BOULEVARD . SOUTH SAN FRANCISCO CA 94080 (650) 624-3000
CYTOKINETICS INC (Filer) CIK: 0001061983 (see all company filings)

EIN.: 943291317 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50633 | Film No.: 25607684
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)